HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development and immunogenicity of recombinant GapA(+) Mycoplasma gallisepticum vaccine strain ts-11 expressing infectious bronchitis virus-S1 glycoprotein and chicken interleukin-6.

Abstract
Mycoplasma gallisepticum (MG) is a major pathogen of poultry that causes chronic respiratory disease in chickens and infectious sinusitis in turkeys. A live attenuated vaccine, ts-11, has been used for the control of MG in several countries. The efficacy of this vaccine is highly dose dependent and the flock antibody response is weak. To improve the functionality of the vaccine and investigate its potential as a delivery vector for foreign antigens and immunomodulatory proteins, we developed a derivative of ts-11 expressing infectious bronchitis virus-S1 glycoprotein (IBV-S1) and releasing chicken interleukin-6 into the extracellular milieu (MG ts-11 C3 (+CS)) using a transposon-based delivery vector. Following administration of MG ts-11 C3 (+CS) to chickens by eye-drop, an antibody response to MG and IBV-S1, as determined by the rapid serum agglutination test (RSA) and Western blotting, respectively, could be detected. Birds inoculated with the recombinant vaccine had significantly enhanced weight gain and were partially protected against damage by pathogenic IBV. These results indicate that the ChIL-6 released by MG ts-11 C3 (+CS) may have had a non-specific effect on growth rate. They also suggest that ts-11 is a promising vaccine vector, capable of delivering heterologous protective antigens, and may also provide non-specific benefits when engineered to express immunomodulatory proteins. With some improvements in the expression system, it could be used to induce a targeted immune response against specific mucosal pathogens, and co-expression of several antigens would allow development of a novel multivalent vaccine.
AuthorsPollob K Shil, Anna Kanci, Glenn F Browning, Philip F Markham
JournalVaccine (Vaccine) Vol. 29 Issue 17 Pg. 3197-205 (Apr 12 2011) ISSN: 1873-2518 [Electronic] Netherlands
PMID21354248 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Adhesins, Bacterial
  • Antibodies, Bacterial
  • Antibodies, Viral
  • Bacterial Vaccines
  • GapA cytadhesin
  • Interleukin-6
  • Membrane Glycoproteins
  • Spike Glycoprotein, Coronavirus
  • Vaccines, Attenuated
  • Vaccines, Synthetic
  • Viral Envelope Proteins
  • Viral Vaccines
Topics
  • Adhesins, Bacterial (genetics, immunology)
  • Agglutination Tests
  • Animals
  • Antibodies, Bacterial (blood)
  • Antibodies, Viral (blood)
  • Bacterial Vaccines (genetics, immunology)
  • Blotting, Western
  • Body Weight
  • Chickens
  • Coronavirus Infections (immunology, pathology, prevention & control, veterinary)
  • Interleukin-6 (genetics, immunology)
  • Membrane Glycoproteins (genetics, immunology)
  • Mycoplasma gallisepticum (genetics, immunology)
  • Poultry Diseases (immunology, pathology, prevention & control)
  • Spike Glycoprotein, Coronavirus
  • Vaccines, Attenuated (genetics, immunology)
  • Vaccines, Synthetic (genetics, immunology)
  • Viral Envelope Proteins (genetics, immunology)
  • Viral Vaccines (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: